Balloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era
Cardiology · 2024
DOI: 10.1159/000538521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2024. Verfasst von Omar Aldalati und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Balloon Valvuloplasty, Percutaneous Coronary Intervention, Aortic Valve Stenosis. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The role of balloon aortic valvuloplasty (BAV) in the era of transcatheter aortic valve replacement remains a topic of debate. We sought to study the safety and feasibility of combined BAV and percutaneous coronary intervention (BAV-PCI).
Methods
Between November 2009 and July 2020, all patients undergoing BAV were identified and divided into three groups: combined BAV-PCI (group A), BAV with significant unrevascularised CAD (group B), and BAV without significant CAD (group C). Procedural outcomes and 30-day and one-year mortality were compared.
Results
A total of 264 patients were studied (n = 84, 93, and 87 patients in groups A, B, and C, respectively). The STS score was 10.2 ± 8, 13.3 ± 19, and 8.1 ± 7, p = 0.026, in groups A, B, and C, respectively. VARC-3 adjudicated complications were similar among groups (11%, 13%, and 5%, respectively, p = 0.168, respectively). Thirty-day and one-year mortality were 9.8% (n = 26) and 32% (n = 86) of the entire cohort. The differences among groups did not reach statistical significance. Using univariate Cox regression analysis, group B patients were at higher risk of dying compared to group A patients (HR 1.58, 95% CI: 1.11–2.25, p = 0.010). With multivariate Cox regression analysis, the predictors of mortality were STS score, cardiogenic shock, mode of presentation, and lack of subsequent definitive valve intervention.
Conclusion
In high-risk patients with aortic valve stenosis, combined BAV-PCI is safe and feasible with comparable outcomes to BAV with and without significant CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic Department, The James Cook University Hospital, Middlesbrough, UK.
- Cardiothoracic Directorate, University Hospital of Wales, Cardiff, UK.
Zitieren
APA
Aldalati, O., Jackson, M., Vijayan, S., Telyuk, P., Hayat, U., Bashir, S., Vahabi, S., McCalmont, G., de Belder, M. A., Muir, D., & Williams, P. D. (2024). Balloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era. Cardiology. https://doi.org/10.1159/000538521
Vancouver
Aldalati O, Jackson M, Vijayan S, Telyuk P, Hayat U, Bashir S, et al. Balloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era. Cardiology. 2024. doi:10.1159/000538521
BibTeX
@article{Aldalati2024,
author = {Aldalati, Omar and Jackson, Matthew and Vijayan, Seth and Telyuk, Pyotr and Hayat, Umair and Bashir, Shaza and Vahabi, Sharareh and McCalmont, Gemma and de Belder, Mark A and Muir, Douglas and Williams, Paul D},
title = {Balloon Aortic Valvuloplasty with or without Percutaneous Coronary Intervention in the Transcatheter Aortic Valve Replacement Era},
journal = {Cardiology},
year = {2024},
doi = {10.1159/000538521}
}
EUVIMED